Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,763,630
+$87,549 QoQ
Shares Held
24,015
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#314
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMG National Trust Bank holds $56,438,904 across 11 Drug Manufacturers - General names. NVS ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,612 | $17,679,358 | |
| 2 | LLY |
ELI LILLY & Co
|
10,861 | $13,027,009 | |
| 3 | ABBV |
AbbVie Inc.
|
22,461 | $5,652,084 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,236 | $5,427,325 | |
| 5 | NVS |
Novartis AG
This page
|
24,015 | $3,763,630 | |
| 6 | AMGN |
Amgen Inc
|
9,854 | $3,568,330 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
26,675 | $3,370,117 | |
| 8 | PFE |
Pfizer Inc
|
63,296 | $1,524,167 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,763,630 | 24,015 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,676,081 | 24,066 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,155,844 | 22,890 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,918,229 | 22,756 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,753,703 | 22,756 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,547,986 | 22,856 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,204,655 | 22,656 | Shares | Other | 2025-02-07 | |
| 2024-09-30 | $2,644,424 | 22,991 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $3,139,186 | 29,487 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $2,884,682 | 29,822 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,011,127 | 29,822 | Shares | Other | 2024-02-08 | |
| 2023-09-30 | $3,047,854 | 29,922 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $3,049,802 | 30,223 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $2,925,508 | 31,799 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $2,904,400 | 32,015 | Shares | Other | 2023-02-08 | |
| 2022-09-30 | $2,433,460 | 32,015 | Shares | Other | 2022-11-04 | |
| 2022-06-30 | $2,707,664 | 32,032 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,800,625 | 66,104 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,772,056 | 65,989 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $5,464,866 | 66,824 | Shares | Other | 2021-10-28 | |
| 2021-06-30 | $6,051,857 | 66,329 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $4,176,638 | 48,861 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $4,604,784 | 48,764 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,773,589 | 31,895 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $2,785,709 | 31,895 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,526,185 | 30,639 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||